[Use of hyaluronidase to correct hyaluronic acid injections in aesthetic medicine].
Abstract
Hyaluronic acid (HA) is the most commonly used filler in aesthetic medicine. However, overcorrections are frequent even with experienced practitioner. Hyaluronidase is an enzyme that hydrolyzes HA. Hyaluronidase has been recently proposed to correct unsatisfactory results of HA injections in aesthetic medicine (overcorrection, asymmetry, Tyndall effect) and to treat immediate complications such as arterial or venous thrombosis. The objective of this technical note was to summarize the literature data regarding the efficacy, safety and technique of use of hyaluronidase. Hyaluronidase may be responsible for allergies. The practitioner should take this risk and the possible drug interactions into account before using this antidote in order to weigh up the risk/benefit ratio.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 재료 | ha
|
히알루론산 | dict | 3 | |
| 재료 | hyaluronic acid
|
히알루론산 | dict | 2 | |
| 시술 | filler
|
필러 주입술 | dict | 1 | |
| 합병증 | asymmetry
|
비대칭 | dict | 1 | |
| 질환 | overcorrections
|
C2347416
Overcorrection Medical Device Problem
|
scispacy | 1 | |
| 질환 | overcorrection
|
C0871026
Overcorrection (psychologic)
|
scispacy | 1 | |
| 질환 | thrombosis
|
C0040053
Thrombosis
|
scispacy | 1 | |
| 질환 | allergies
|
C0020517
Hypersensitivity
|
scispacy | 1 | |
| 기타 | Hyaluronidase
|
scispacy | 1 | ||
| 기타 | HA injections
|
scispacy | 1 | ||
| 기타 | arterial
|
scispacy | 1 | ||
| 기타 | venous
|
scispacy | 1 |
MeSH Terms
Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Iatrogenic Disease; Injections; Plastic Surgery Procedures; Reoperation; Surgery, Plastic
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Choroidal ischemia after self-injection of hyaluronic acid filler.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Intra-articular therapies for synovial joint dysfunction: a comprehensive integrative review.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.